Literature DB >> 28117588

Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.

Andrea Astolfi1, Tommaso Felicetti1, Nunzio Iraci1, Giuseppe Manfroni1, Serena Massari1, Donatella Pietrella1, Oriana Tabarrini1, Glenn W Kaatz2, Maria L Barreca1, Stefano Sabatini1, Violetta Cecchetti1.   

Abstract

An intriguing opportunity to address antimicrobial resistance is represented by the inhibition of efflux pumps. Focusing on NorA, the most important efflux pump of Staphylococcus aureus, an efflux pump inhibitors (EPIs) library was used for ligand-based pharmacophore modeling studies. By exploitation of the obtained models, an in silico drug repositioning approach allowed for the identification of novel and potent NorA EPIs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28117588     DOI: 10.1021/acs.jmedchem.6b01439

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

Review 1.  Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance.

Authors:  Meenal Chawla; Jyoti Verma; Rashi Gupta; Bhabatosh Das
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

Review 2.  Drug repurposing for antimicrobial discovery.

Authors:  Maya A Farha; Eric D Brown
Journal:  Nat Microbiol       Date:  2019-03-04       Impact factor: 17.745

3.  Analysis of antibiotics resistant genes in different strains of Staphylococcus aureus.

Authors:  Benson Otarigho; Mofolusho O Falade
Journal:  Bioinformation       Date:  2018-03-31

4.  Boeravinone B, A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of Staphylococcus aureus and Human P-Glycoprotein, Reduces the Biofilm Formation and Intracellular Invasion of Bacteria.

Authors:  Samsher Singh; Nitin P Kalia; Prashant Joshi; Ajay Kumar; Parduman R Sharma; Ashok Kumar; Sandip B Bharate; Inshad A Khan
Journal:  Front Microbiol       Date:  2017-10-04       Impact factor: 5.640

5.  PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat Staphylococcus aureus-induced skin infections.

Authors:  Minghao Sun; Chune Zhu; Jieyu Long; Chao Lu; Xin Pan; Chuanbin Wu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

6.  Essential Oil, Extracts, and Sesquiterpenes Obtained From the Heartwood of Pilgerodendron uviferum Act as Potential Inhibitors of the Staphylococcus aureus NorA Multidrug Efflux Pump.

Authors:  Javier Espinoza; Alejandro Urzúa; Loreto Sanhueza; Mariana Walter; Paola Fincheira; Patricia Muñoz; Leonora Mendoza; Marcela Wilkens
Journal:  Front Microbiol       Date:  2019-02-26       Impact factor: 5.640

7.  Clinically Approved Drugs Inhibit the Staphylococcus aureus Multidrug NorA Efflux Pump and Reduce Biofilm Formation.

Authors:  Saskia Zimmermann; Mareike Klinger-Strobel; Jürgen A Bohnert; Sindy Wendler; Jürgen Rödel; Mathias W Pletz; Bettina Löffler; Lorena Tuchscherr
Journal:  Front Microbiol       Date:  2019-12-03       Impact factor: 5.640

8.  C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors.

Authors:  Tommaso Felicetti; Gianmarco Mangiaterra; Rolando Cannalire; Nicholas Cedraro; Donatella Pietrella; Andrea Astolfi; Serena Massari; Oriana Tabarrini; Giuseppe Manfroni; Maria Letizia Barreca; Violetta Cecchetti; Francesca Biavasco; Stefano Sabatini
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

9.  Acute, subacute oral toxicity and Ames test of Py-mulin: an antibacterial drug candidate.

Authors:  Yuan Fan; Yunxing Fu; Yuhang Zhou; Yu Liu; Baocheng Hao; Ruofeng Shang
Journal:  BMC Pharmacol Toxicol       Date:  2022-01-04       Impact factor: 2.483

10.  Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors.

Authors:  Rolando Cannalire; Gianmarco Mangiaterra; Tommaso Felicetti; Andrea Astolfi; Nicholas Cedraro; Serena Massari; Giuseppe Manfroni; Oriana Tabarrini; Salvatore Vaiasicca; Maria Letizia Barreca; Violetta Cecchetti; Francesca Biavasco; Stefano Sabatini
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.